Short-term stability of subtypes in the irritable bowel syndrome: Prospective evaluation using the Rome III classification

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 3, 2012, Pages 350-359

  Engsbro, A L ^a   Simren, M ^b   Bytzer, P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROBIOTIC AGENT; YOGHURT;

ADULT; AGED; ARTICLE; BRISTOL STOOL FORM SCALE; CLINICAL EVALUATION; CONSTIPATION; CONTROLLED STUDY; DEFECATION; DIARRHEA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FECES ANALYSIS; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ROME III CLASSIFICATION; SCORING SYSTEM;

ADULT; COHORT STUDIES; CONSTIPATION; DEFECATION; DIARRHEA; FEMALE; GASTROINTESTINAL TRANSIT; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84855358885     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04948.x     Document Type: Article

References (28)

1. Spiegel BM,. The burden of IBS: looking at metrics. Curr Gastroenterol Rep 2009; 11: 265-9.
2. Choung RS, Locke GR III,. Epidemiology of IBS. Gastroenterol Clin North Am 2011; 40: 1-10.
3. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC,. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
4. O'Donnell LJ, Virjee J, Heaton KW,. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ 1990; 300: 439-40. (Pubitemid 20069266)
5. Coletta M, Di PL, Tomba C, Basilisco G,. Discrepancy between recalled and recorded bowel habits in irritable bowel syndrome. Aliment Pharmacol Ther 2010; 32: 282-8.
6. Deiteren A, Camilleri M, Bharucha AE, et al. Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions. Neurogastroenterol Motil 2010; 22: 415-23.
7. Lewis SJ,. Stool form scale as a useful guide to intestinal transit time. 1997.
8. American Gastroenterological Association medical position statement: irritable bowel syndrome. Gastroenterology 2002; 123: 2105-7.
9. Brandt LJ, Chey WD, Foxx-Orenstein AE, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104 (Suppl 1): S1-35.
10. Mayer EA,. Clinical practice. Irritable bowel syndrome. N Engl J Med 2008; 358: 1692-9.
11. Quigley E, Fried M, Gwee KA, et al. WGO Practice Guideline-irritable bowel syndrome: a global perspective. Available at:. 2009. Accessed July 25, 2011.
12. Spiller R, Aziz Q, Creed F, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007; 56: 1770-98. (Pubitemid 350206308)
13. Spiller RC, Thompson WG,. Bowel disorders. Am J Gastroenterol 2010; 105: 775-85.
14. WGO advisory board. Systematic review on the Management of irritable bowel syndrome in the European Union. Eur J Gastroenterol Hepatol 2007; 19: S11-37.
15. Simren M, Ohman L, Olsson J, et al. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome-a randomized, double-blind, controlled study. Aliment Pharmacol Ther 2010; 31: 218-27.
16. Sondergaard B, Olsson J, Ohlson K, Svensson U, Bytzer P, Ekesbo R,. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial. Scand J Gastroenterol 2011; 46: 663-72.
17. Thompson WG, Longstreth GF, Drossman DA, Heaton K, Irvine EJ, Müller-Lissner SA,. Functional bowel disorders. In:, Drossman DA, Corrazziari E, Talley N, Thompson WG, Whitehead WE, eds. Rome II: The Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology and Treatment. A Multinational Consensus. McLean, Virginia, USA: Degnon Associates, 2000: 351-432.
18. Altman DG,. Practical Statistics for Medical Research. 1st ed. Florida: Chapman & Hall/CRC, 1991.
19. Penny KI, Smith GD, Ramsay D, Steinke DT, Kinnear M, Penman ID,. An examination of subgroup classification in irritable bowel syndrome patients over time: a prospective study. Int J Nurs Stud 2008; 45: 1715-20.
20. Drossman DA, Morris CB, Hu Y, et al. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology 2005; 128: 580-9. (Pubitemid 40585359)
21. Halder SL, Locke GR III, Schleck CD, Zinsmeister AR, Melton LJ III, Talley NJ,. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 2007; 133: 799-807.
22. Guilera M, Balboa A, Mearin F,. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review. Am J Gastroenterol 2005; 100: 1174-84. (Pubitemid 40769059)
23. Garrigues V, Mearin F, Badia X, et al. Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study). Aliment Pharmacol Ther 2007; 25: 323-32. (Pubitemid 46115402)
24. Dorn SD, Morris CB, Hu Y, et al. Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar. J Clin Gastroenterol 2009; 43: 214-20.
25. Williams RE, Black CL, Kim HY, et al. Stability of irritable bowel syndrome using a Rome II-based classification. Aliment Pharmacol Ther 2006; 23: 197-205. (Pubitemid 43381184)
26. Mearin F, Baro E, Roset M, Badia X, Zarate N, Perez I,. Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability. Am J Gastroenterol 2004; 99: 113-21. (Pubitemid 38679112)
27. Tillisch K, Labus JS, Naliboff BD, et al. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome. Am J Gastroenterol 2005; 100: 896-904. (Pubitemid 40592385)
28. Ford AC, Moayyedi P,. Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Aliment Pharmacol Ther 2010; 32: 144-58.